Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $2.51 Million - $2.76 Million
2,781 Added 114.12%
5,218 $5.02 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $55,812 - $63,482
72 Added 3.04%
2,437 $2.14 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $2,077 - $2,533
3 Added 0.13%
2,365 $1.95 Million
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $122,505 - $145,311
175 Added 8.0%
2,362 $1.7 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $5,443 - $6,615
8 Added 0.37%
2,187 $1.8 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $210,355 - $228,384
298 Added 15.84%
2,179 $1.57 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $127,421 - $160,799
-222 Reduced 10.56%
1,881 $1.3 Million
Q2 2022

Aug 11, 2022

BUY
$548.35 - $738.84 $67,995 - $91,616
124 Added 6.27%
2,103 $1.24 Million
Q1 2022

May 12, 2022

BUY
$595.12 - $698.43 $33,326 - $39,112
56 Added 2.91%
1,979 $1.38 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $24,456 - $30,193
-45 Reduced 2.29%
1,923 $1.21 Million
Q3 2021

Nov 16, 2021

BUY
$574.03 - $680.96 $94,140 - $111,677
164 Added 9.09%
1,968 $1.19 Million
Q2 2021

Aug 13, 2021

SELL
$472.8 - $558.54 $4,728 - $5,585
-10 Reduced 0.55%
1,804 $1.01 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $178,245 - $218,731
399 Added 28.2%
1,814 $858,000
Q4 2020

Feb 17, 2021

BUY
$478.3 - $607.98 $420,904 - $535,022
880 Added 164.49%
1,415 $684,000
Q3 2020

Nov 13, 2020

SELL
$544.75 - $658.21 $149,261 - $180,349
-274 Reduced 33.87%
535 $299,000
Q2 2020

Aug 13, 2020

SELL
$493.32 - $643.92 $310,791 - $405,669
-630 Reduced 43.78%
809 $505,000
Q1 2020

May 08, 2020

BUY
$336.18 - $494.43 $483,763 - $711,484
1,439 New
1,439 $703,000
Q4 2018

Feb 15, 2019

SELL
$335.82 - $403.04 $319,700 - $383,694
-952 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$351.14 - $408.51 $334,285 - $388,901
952 New
952 $382,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.